These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 23114759)
1. The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens. Randall CP; Mariner KR; Chopra I; O'Neill AJ Antimicrob Agents Chemother; 2013 Jan; 57(1):637-9. PubMed ID: 23114759 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens. Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329 [TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of N-acetylcysteine against bacteria colonising central venous catheters. Mansouri MD; Darouiche RO Int J Antimicrob Agents; 2007 Apr; 29(4):474-6. PubMed ID: 17293092 [No Abstract] [Full Text] [Related]
5. Comparison of the in vitro susceptibility of veterinary antibiotics with human antibiotics within aminoglycosides, β-lactam and fluoroquinolone antibiotic classes to highly resistant Gram-negative pathogens from human medicine. Moore JE; Alcorn M; Rendall JC; Downey DG Br J Biomed Sci; 2015; 72(3):146-9. PubMed ID: 26510272 [No Abstract] [Full Text] [Related]
6. Effect of antibiotics on endotoxin release from gram-negative bacteria. Eng RH; Smith SM; Fan-Havard P; Ogbara T Diagn Microbiol Infect Dis; 1993; 16(3):185-9. PubMed ID: 8477572 [TBL] [Abstract][Full Text] [Related]
7. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens. Landini G; Di Maggio T; Sergio F; Docquier JD; Rossolini GM; Pallecchi L Antimicrob Agents Chemother; 2016 Dec; 60(12):7513-7517. PubMed ID: 27736757 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436 [TBL] [Abstract][Full Text] [Related]
9. Arginine-lysine positional swap of the LL-37 peptides reveals evolutional advantages of the native sequence and leads to bacterial probes. Wang X; Junior JCB; Mishra B; Lushnikova T; Epand RM; Wang G Biochim Biophys Acta Biomembr; 2017 Aug; 1859(8):1350-1361. PubMed ID: 28450045 [TBL] [Abstract][Full Text] [Related]
10. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida. Morris CM; George A; Wilson WW; Champlin FR J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392 [TBL] [Abstract][Full Text] [Related]
11. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens. Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633 [TBL] [Abstract][Full Text] [Related]
12. Salt-resistant short antimicrobial peptides. Mohanram H; Bhattacharjya S Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria. Laudy AE; Kulińska E; Tyski S Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment. Ramzi A; Oumokhtar B; Ez Zoubi Y; Filali Mouatassem T; Benboubker M; El Ouali Lalami A Biomed Res Int; 2020; 2020():6509740. PubMed ID: 33381566 [TBL] [Abstract][Full Text] [Related]
15. The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts. Elisha IL; Botha FS; McGaw LJ; Eloff JN BMC Complement Altern Med; 2017 Feb; 17(1):133. PubMed ID: 28241818 [TBL] [Abstract][Full Text] [Related]
16. A promising target for treatment of multidrug-resistant bacterial infections. Davey MS; Tyrrell JM; Howe RA; Walsh TR; Moser B; Toleman MA; Eberl M Antimicrob Agents Chemother; 2011 Jul; 55(7):3635-6. PubMed ID: 21537011 [No Abstract] [Full Text] [Related]
17. Antibacterial activity of Quercus ilex bark's extracts. Berahou A; Auhmani A; Fdil N; Benharref A; Jana M; Gadhi CA J Ethnopharmacol; 2007 Jul; 112(3):426-9. PubMed ID: 17513077 [TBL] [Abstract][Full Text] [Related]